Manuscripts
Showing 1530 manuscripts.
Intestinal Integrity Biomarkers in Early Antiretroviral-Treated Perinatally HIV-1-Infected Infants.
Citation
WLA Koay, JC Lindsey, P Uprety, M Bwakura-Dangarembizi, A Weinberg, MJ Levin, D Persaud. Intestinal Integrity Biomarkers in Early Antiretroviral-Treated Perinatally HIV-1-Infected Infants.. Journal of Infectious Diseases. 2018. 218: 1085-1089. PMID: 29762690Year
2018
Journal
Journal of Infectious Diseases
Study
P1072
Rilpivirine Plasma and Cervicovaginal Concentrations in Women During Pregnancy and Postpartum
Citation
Ahizechukwu C Eke, Nahida Chakhtoura, Angela Kashuba, Brookie M Best, Craig Sykes, Jiajia Wang, Alice M Stek, Elizabeth Smith, Samantha Calabrese, Edmund V Capparelli, Mark Mirochnick, IMPAACT P1026s Protocol Team. Rilpivirine Plasma and Cervicovaginal Concentrations in Women During Pregnancy and Postpartum. Journal of Acquired Immune Deficiency Syndromes. 2018. 78: 308-313. PMID: 29528944Year
2018
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1026S
Changing patterns and predictors of mode of delivery among HIV-infected pregnant women in the United States from 1998 to 2013: Results from two multi-site cohorts
Citation
Kartik Venkatesh, Leavitt Morrison, Elizabeth Livingston, Alice Stek, Jennifer Read, David Shapiro, Ruth Tuomala. Changing patterns and predictors of mode of delivery among HIV-infected pregnant women in the United States from 1998 to 2013: Results from two multi-site cohorts. Obstetrics and Gynecology. 2018. 131: 879-890. PMID: 29630021Year
2018
Journal
Obstetrics and Gynecology
Birth Outcomes for Pregnant Women with HIV Using Tenofovir-Emtricitabine.
Citation
Kathryn Rough, George R Seage III, Paige L Williams, Sonia Hernandez-Diaz, Yanling Huo, Ellen G Chadwick, Judith S Currier, Risa M Hoffman, Emily Barr, David E Shapiro, Kunjal Patel, PHACS and IMPAACT P1025 study team. Birth Outcomes for Pregnant Women with HIV Using Tenofovir-Emtricitabine.. New England Journal of Medicine. 2018. 378: 1593-1603. PMID: 29694825Year
2018
Journal
New England Journal of Medicine
Study
P1025
Persistence of memory B-cell and T-cell responses to the quadrivalent HPV vaccine in HIV-infected children.
Citation
Weinberg A, Huang S, Moscicki AB, Saah A, Levin MJ, IMPAACT P1085 Protocol Team. Persistence of memory B-cell and T-cell responses to the quadrivalent HPV vaccine in HIV-infected children.. AIDS. 2018. 32: 851-860. PMID: 29424778Year
2018
Journal
AIDS
Study
P1085
Live-attenuated Respiratory Syncytial virus Vaccine Candidate with Deletion of RNA Synthesis Regulatory Protein M2-2 is highly Immunogenic in Children
Citation
Elizabeth McFarland, Ruth Karron, Petronella Muresan, Coleen Cunningham, Megan Valentine, Charlotte Perlowski, Bhagvanji Thumar, Devasena Gnanashanmugam, Geroge Siberry, Elizabeth Schappell, Emily Barr, Vivian Rexroad, Ram Yogev, Stephen Spector, Miram Aziz, Nehali Patel, Mikhaela Cielo, Cindy Luongo, Peter Collins, Ursula Buchholz. Live-attenuated Respiratory Syncytial virus Vaccine Candidate with Deletion of RNA Synthesis Regulatory Protein M2-2 is highly Immunogenic in Children. Journal of Infectious Diseases. 2018. 217: 1347-1355. PMID: 29509911Year
2018
Journal
Journal of Infectious Diseases
Study
IMPAACT 2000
Live respiratory syncytial virus (RSV) vaccine with stabilized temperature sensitivity mutations is highly attenuated in RSV seronegative infants and children
Citation
Ursula Buchholz, Coleen Cunningham, Petronella Muresan, Devasena Gnanashanmugam, Paul Sato, George Siberry, Vivian Rexroad, Megan Valentine, Charlotte Perlowski, Elizabeth Schappell, Bhagvinji Thumar, Cindy Luongo, Emily Barr, Mariam Aziz, Ram Yogev, Stephen Spector, Peter Collins, Elizabeth McFarland, Ruth Karron, The P1114 Study Team. Live respiratory syncytial virus (RSV) vaccine with stabilized temperature sensitivity mutations is highly attenuated in RSV seronegative infants and children. Journal of Infectious Diseases. 2018. 217: 1338-1346. PMID: 29509929Year
2018
Journal
Journal of Infectious Diseases
Study
P1114
Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE): A Randomized, Open-Label, Clinical Trial
Citation
Patricia M Flynn, Taha E Taha, Mae Cababasay, Mary Glenn Fowler, Lynne Mofenson, Mazensia Owor, Susan Fiscus, Lynda Stranix-Chibanda, Anna Coutsoudis, Devasena Gnanashanmugam, Nahida Chakhtoura, Katie McCarthy, Cornelius Mukuzunga, Bonus Makanani, Dhayendre Moodley, Teacler Nematadzira, Bangini Kusakara, Sandesh Patil, Tichaona Vhembo, Raziya Bobat, Blandina Mmaga, Maysseb Masenya, Mandisa Nyati, Gerhard Theron, Helen Mulenga, David E Shapiro, The PROMISE Team. Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE): A Randomized, Open-Label, Clinical Trial. Journal of Acquired Immune Deficiency Syndromes. 2018. 77: 383-392. PMID: 29239901Year
2018
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
1077BF
Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV
Citation
Nikki Mulligan, Brookie M Best, Jiajia Wang, Edmund V Capparelli, Alice Stek, Emily Barr, Shelley L Buschur, Edward P Acosta, Elizabeth Smith, Nahida Chakhtoura, Sandra Burchett, Mark Mirochnick, IMPAACT P1026s Protocol Team. Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV. AIDS. 2018. 32: 729-737. PMID: 2969162Year
2018
Journal
AIDS
Study
P1026S
Defining Study Outcomes That Better Reflect Individual Response to Treatment
Citation
Konstantia Angelidou, Paul Palumbo, Jane Lindsey, Avy Violary, Moderndran Archary, Linda Barlow, Brian Claggett, Michael Hughes, Lee-Jen Wei, IMPAACT P1060 Study Team. Defining Study Outcomes That Better Reflect Individual Response to Treatment. 2018. PMID: 29189677Year
2018
Study
P1060